Answered You can buy a ready-made answer or pick a professional tutor to order an original one.
Assignment 2 : methodology
In your final paper for this course, you will need to write a Methods section that is about 3–4 pages long where you will assess and evaluate the methods and analysis of your proposed research.
In preparation for this particular section, answer the following questions thoroughly and provide justification/support. The more complete and detailed your answers for these questions, the better prepared you are to successfully write your final paper:
- What is the problem being addressed by your research study?
- State the refined research question and hypothesis (null and alternative).
- What are your independent and dependent variables? What are their operational definitions?
- Who will be included in your sample (i.e., inclusion and exclusion characteristics)?
- How many participants will you have in your sample?
- How will you recruit your sample?
- Identify the type of measurement instrument to be used to collect the raw numeric data to be statistically analyzed and the type of measurement data the instrument produces.
- What issues will you cover in the informed consent?
- If there is potential risk or harm, how will you ensure the safety of all participants?
- Name any possible threats to validity and steps that can be taken to minimize these threats.
- What type of parametric or nonparametric inferential statistical process (correlation, difference, or effect) will you use in your proposed research? Why is this statistical test the best fit?
- State an acceptable behavioral research alpha level you would use to fail to accept or fail to reject the stated null hypothesis and explain your choice.
This paper may be written in question-and-answer format rather than a flowing paper. Write your response in a 3- to 4-page Microsoft Word document.
All written assignments and responses should follow APA rules for attributing sources.
- @
- 12 orders completed
- ANSWER
-
Tutor has posted answer for $15.00. See answer's preview
*************** ** the ***************** *************** ** ************** ** *** ******* being ********* by your ******** ********* ******* ***** **** ** ***** ***** **** by this ******** paper ** *** ***** ** *** increasing number of ****** suffering from *********** diseases ***** of ****** hay ***** ********* *** ****** ********** ***** *********** problems have wide ****** all ****** ******* It **** shows *** various **** ** *********** or ******** ***** diseases (White E * ***** **** ****** ***** **** **** ******** that tend to ******* such infections **** **** *** curbed *** *************** *** refined research ******** and hypothesis ***** *** alternative)The pure ******** ******** is what are ********* ****** ** **** ******** **** ********** may **** ** *** ********* ** **** disease *** **** ** **** ***** on *** ******* **** ** *********** *** ********** ** **** diseases *********** * ***** *** ******** **** *********** ** **** ****** infected **** *** ******** *** **** ***** who *** ************ are **** *********** *** ********* ********** What *** ***** *********** definitions?The *********** variable ** *** **** ** ********* **** ** ************ to **** ********* this can ** ******* ***** ** will ****** ** the ****** *** ********** of *** doctor *** ** ****** ****** ** treating the ******* *** ********* ******** is ********* vaccines **** are ***** to *** ******** ** **** them curb ***** ********** ****** Z ***** Their *********** definitions *** *** ******* ***** ************ **** ** ******** ** your sample *** ********* *** ********* characteristics)?The population **** ** ******** *** **** of ******** ****** together **** *** ******* ** **** ***** **** ** ******** ** *** ***** The stakeholders ** *** ***** ** this ******* **** also ** included ** *** ****** ****** A * 2016) The patients *** previously ******** **** kind of ******* **** **** be included in the study to help ** giving *** *** correct ***** *** ******** of ******* *********** diseasesHow **** ************ **** *** **** in your ********** ************ **** ******* ********** ******** *** *** *********** ******** ** *** *********** ******** *** patients who have **** ******** ** the various hospitals ****** *** **** issue ** these diseases *** ********* doctors who **** **** ** ********** information concerning *** ***** and symptoms ** *** ******** (Metersky * * ***** *** ************ **** ** threeHow **** *** ******* your ************ is to ********* the *********** ******* which is mostly ******* *** use ** ****** ***** ** ** *** ******* channel ******* *** ** ******* making the *********** ***** *** straightforward ******* ****** ***** ******* ********* Sending a ******* survey ***** ***** members join the ***** **** **** **** ** ********** information of **** ****** (Palmer L * ***** ****** is ******* * ******* email ** *** selected *************** *** **** ** *********** ********** ** ** **** ** ******* *** raw ******* **** to ** statistically ******** and *** **** ** *********** **** the device *********** ******* measurement ****** ** spirometer; this ***** in ********* vital ******** *** ****** ********** ******* ** assists ** providing *************** ******* restrictive *** *********** respiratory diseases The *********** **** **** the instrument ******** ** relatively ****** ** compared to ******* **** ** ************ issues **** *** ***** in *** informed ************** **** **** *** be done ** *** ******** *** them to be **** **** ************* ******** **** ***** be *** ** ***** ** **** **** ***** *********** ** **** ******* * will **** ***** what ***** ******* ******** **** *** ** ****** by ***** ********** *** ****** * would like ** ******* *** effects ***** conditions *** ***** for ******* like ***** *** loss ** ****** (Schoenberg * C ***** Another ***** **** * **** ***** **** be **** can ** **** ** ****** ***** *** ********* ***** ** *** spread ** ***** ********** ***** is ********* **** or **** *** will *** ****** the ****** of *** ****************** there ** ** *** **** **** may ****** *** ************ ** **** research I would *** ******** ** ***** to ******* them **** contracting **** any skin ********* diseases ******* ****** **** ****** ** places **** ********* ********** **** those ** **** ** ********* **** the disease **** I **** ******* **** **** ********* ***** ** curb the *************** any ******** ******* ** ******** *** steps that *** ** taken ** minimize these ********* ** *** threats **** include ****** ********* **** *** ******** community ********** when ******* researching questioners **** ****** *** **** ** ** ******* ** *** *************** **** *** ******* **** I would minimize the ***** ******* educating *** ****** ** what is *** ********** ** disseminating **** *********** ********* J ***** ******* ******* **** ** ********* *** ************ ** the ***** ***** there *** few ***** of *** infection as **** **** deliver ******** *********** ** *** *** ********* type ** parametric ** ************* *********** *********** ******* ************ ********** ** ******* will *** *** ** *** ******** ********* *** ** **** statistical **** the **** ******* **** ************* inferential *********** ******* is the correlation this ******* it shows * ***** range ** details ********** *** study *** ******* ** shows *** data ** ******** ***** the infection ** *** ******** **** ** ******* ********* ** ********* ******* ** times ******* * * 2017) It will *********** how ******* ****** o ******** ** *** ********** area can ** inferred ** *** **** ***** ** *** ******* ******** **** ***** ** giving ***** ******* of *** ********** ** ********** ********** ******** ***** ***** *** ***** *** ** fail ** accept or fail ** ****** *** ****** **** ********** and explain **** choiceThe ********** ********** ******** ***** level **** * ***** **** ** use ** * percent **** ***** ***** exceeds this value ******** **** **** behavior **** **** ** ****** *** stated **** hypothesis this ******* *** information ******** will be denied (Samet * M ***** ** *** sample **** of the ********** ** *********** ****** **** ** will ****** *** ******** ** ** **** **** ********************* * S ***** * Brown K * ********** * ******** * ******* R * & **** * (2016) An ******** thoracic ******* official ******** ********** ****** ********** ** lung ******** research ******** ******* ** *********** *** critical **** medicine ****** ************ * * ******** M L Klompas * ********* * Sweeney * * ****** * B ***** ** Solh A * ****** ********** of ****** with ***************** and ventilator-associated pneumonia: **** ******** ******** ********** ** *** ********** ******** ******* of ******* *** *** ******** ******** Society Clinical ********** ******** ***** ****************** N * Barker * * Bernardo * ********* * * Ellner * J **** D * ***** ****** * * (2017) * *********** Analysis of ********* *** ******** Care ******** ********* *********** Methodologies ******** ******* ** *********** *** Critical **** ******** ********* * M ****** ************ and the ******* ********* How ******** ** ******* *** ****** Shaped ************ ******** ******* of ************ 183(5) *******